Astrana Health (NASDAQ:ASTH) Shares Up 4.9% – Time to Buy?

Shares of Astrana Health, Inc. (NASDAQ:ASTH) traded up 4.9% on Monday . The stock traded as high as $32.91 and last traded at $32.7460. 53,628 shares were traded during trading, a decline of 84% from the average session volume of 336,965 shares. The stock had previously closed at $31.21.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on the stock. Zacks Research upgraded shares of Astrana Health from a “strong sell” rating to a “hold” rating in a report on Friday, October 10th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Astrana Health in a report on Wednesday, October 8th. Four equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $47.40.

Astrana Health Price Performance

The company has a debt-to-equity ratio of 0.52, a current ratio of 1.59 and a quick ratio of 1.59. The company has a market cap of $1.85 billion, a price-to-earnings ratio of 64.71, a P/E/G ratio of 0.90 and a beta of 0.80. The company’s 50-day simple moving average is $30.37 and its 200-day simple moving average is $27.86.

Astrana Health (NASDAQ:ASTH) last released its quarterly earnings results on Wednesday, January 10th. The company reported $0.50 earnings per share for the quarter. Astrana Health had a net margin of 1.04% and a return on equity of 3.43%. The business had revenue of $317.00 million during the quarter. On average, equities research analysts anticipate that Astrana Health, Inc. will post 1.15 EPS for the current year.

Institutional Trading of Astrana Health

A number of hedge funds have recently made changes to their positions in ASTH. Covestor Ltd lifted its stake in Astrana Health by 777.6% during the first quarter. Covestor Ltd now owns 2,001 shares of the company’s stock worth $62,000 after purchasing an additional 1,773 shares during the last quarter. Tower Research Capital LLC TRC raised its stake in shares of Astrana Health by 323.3% during the second quarter. Tower Research Capital LLC TRC now owns 4,605 shares of the company’s stock valued at $115,000 after purchasing an additional 3,517 shares in the last quarter. State of Wyoming bought a new stake in shares of Astrana Health during the second quarter valued at about $132,000. AlphaQuest LLC raised its stake in shares of Astrana Health by 144.2% during the first quarter. AlphaQuest LLC now owns 4,883 shares of the company’s stock valued at $151,000 after purchasing an additional 2,883 shares in the last quarter. Finally, US Bancorp DE grew its holdings in Astrana Health by 21.3% during the first quarter. US Bancorp DE now owns 5,791 shares of the company’s stock worth $180,000 after acquiring an additional 1,015 shares during the period. Institutional investors and hedge funds own 52.77% of the company’s stock.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.